HLA-A alleles of patients with pyothorax-associated lymphoma: Anti-epstein-barr virus (EBV) host immune responses during the development of EBV latent antigen-positive lymphomas

International Journal of Cancer

Volumn 82, Issue 5, 1999, Pages 630-634

  Kanno, Hiroyuki ^a   Ohsawa, Masahiko ^a   Hashimoto, Michiko ^a   Iuchi, Keiji ^b   Nakajima, Yutsuki ^c   Aozasa, Katsuyuki ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b National Kinki Chuo Hospital   (Japan)

^c RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN CLASS 1; VIRUS ANTIGEN; CELL NUCLEUS ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

AGED; ALLELE; ARTICLE; B LYMPHOCYTE; CELL CULTURE; EPSTEIN BARR VIRUS; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOMA; MALE; METABOLISM; MIDDLE AGED; PLEURA EMPYEMA; POLYMERASE CHAIN REACTION; VIROLOGY; ADULT; ANIMAL CELL; ANTIGEN EXPRESSION; CLINICAL ARTICLE; GENE LOCUS; HUMAN CELL; IMMUNE RESPONSE; LATENT VIRUS INFECTION; LYMPHOBLASTOID CELL LINE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AGED; ALLELES; ANTIGENS, VIRAL; B-LYMPHOCYTES; EMPYEMA, PLEURAL; FEMALE; HERPESVIRUS 4, HUMAN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-A ANTIGENS; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0033609697     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990827)82:5<630::AID-IJC2>3.0.CO;2-D     Document Type: Article

References (27)

1. AKAZA, T., IMANISHI, T., FUJIWARA, K., TOKUNAGA, K., JUJI, T., YASHIKI, S. and SONODA, S., HLA allele and haplotype frequencies [in Japanese]. Transplantation Now, 7(Suppl.), 87-99 (1994).
2. ANDERSSON, M.L., STAM, N.J., KLEIN, G., PLOEGH, H.L. and MASUCCI, M.G., Aberrant expression of HLA class I antigens in Burkitt lymphoma cells. Int. J. Cancer, 47, 544-550 (1991).
3. BROWNING, M.J., KRAUSA, P., ROWAN, A., BICKNELL, D.C., BOOMER, J.G. and BOOMER, W.F., Tissue typing the HLA-A locus from genomic DNA by sequence-specific PCR: comparison of HLA genotype and surface expression on colorectal tumor cell lines. Proc. nat. Acad. Sci. (Wash.), 90, 2842-2845 (1993).
4. DE CAMPOS-LIMA, P.O., LEVITSKY, V., BROOKS, J., LEE, S.P., Hu, L.F., RICKINSON, A.B. and MASUCCI, M.G., T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues. J. exp. Med., 179, 1297-1305 (1994).
5. FUKAYAMA, M., IBUKA, T., HAYASHI, Y., OOBA, T., KOIKE, M. and MIZUTANI, S., Epstein-Barr virus in pyothorax-associated pleural lymphoma. Amer. J. Pathol., 143, 1044-1049 (1993).
6. GAVIOLI, R., DE CAMPOS-LIMA, P.O., KURILLA, M.G., KIEFF, E., KLEIN, G. and MASUCCI, M.G., Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma. Proc. nat. Acad. Sci. (Wash.), 89, 5862-5866 (1992).
7. IUCHI, K., AOZASA, K., YAMAMOTO, S., MORI, T., TAJIMA, T., MINATO, K., MUKAI, K., KOMATSU, H., TAGAKI, T., KOBASHI, Y., YAMABE, H. and SHIMOYAMA, M., Non-Hodgkin's lymphoma of the pleural cavity developing from long-standing pyothorax. Summary of clinical and pathological findings in thirty-seven cases. Jpn. J. clin. Oncol., 19, 249-257 (1989).
8. IUCHI, K., ICHIMIYA, A., AKASHI, A., MIZUTA, T., LEE, Y.-E., TADA, H., MORI, T., SAWAMURA, K., LEE, Y.-S., FURUSE, K., YAMAMOTO, S. and AOZASA, K., Non-Hodgkin's lymphoma of the pleural cavity developing from long-standing pyothorax. Cancer, 60, 1771-1775 (1987).
9. 2-microglobulin in colorectal cancer. Int. J. Cancer, 51, 379-385 (1992).
10. KANNO, H., NAKA, N., YASUNAGA, Y., IUCHI, K., YAMAUCHI, S., HASHIMOTO, M. and AOZASA, K., Production of the immunosuppressive cytokine interleukin-10 by Epstein-Barr-virus-expressing pyothorax-associated lym-phoma: possible role in the development of overt lymphoma in immunocompetent hosts. Amer. J. Pathol., 150, 349-357 (1997).
11. KANNO, H., WOLFINBARGER, J.B. and BLOOM, M.E., Aleutian mink disease parvovirus infection of mink peritoneal macrophages and human macrophage cell lines. J. Virol., 67, 2075-2082 (1993).
12. KANNO, H., YASUNAGA, Y., OHSAWA, M., TANIWAKI, M., IUCHI, K., NAKA, N., TORIKAI, K., SHIMOYAMA, M. and AOZASA, K., Expression of Epstein-Barr virus latent infection genes and oncogenes in lymphoma cell lines derived from pyothorax-associated lymphoma. Int. J. Cancer, 67, 86-94 (1996).
13. KHANNA, R., BURROWS, S.R., KURILLA, M.G., JACOB, C.A., MISKO, I.S., SCULLEY, T.B., KIEFF, E. and MOSS, D.J., Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. J. exp. Med., 176, 169-176 (1992).
14. KIMURA, A., DATE, Y. and SASAZUKI, T., DNA typing of HLA-A gene [in Japanese]. Transplantation Now, 7(Suppl.), 10-22 (1994).
15. KRAUSA, P., BODMER, J.G. and BROWNING, M.J., Defining the common subtypes of HLA A9, A10, A28 and A19 by use of ARMS/PCR. Tissue Antigens, 42, 91-99 (1993).
16. LEE, S.P., THOMAS, W.A., MURRAY, R.J., KHANIM, F., KAUR, S., YOUNG, L.S., ROWE, M., KURILLA, M. and RICKINSON, A.B., HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2. J. Virol., 67, 7428-7435 (1993).
17. MASUCCI, M.G., TORSTEINSDOTTIR, S., COLOMBANI, J., BRAUTBAR, C., KLEIN, E. and KLEIN, G., Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines. Proc. nat. Acad. Sci. (Wash.), 84, 4567-4571 (1987).
18. MÖLLER, P., HERRMANN, B., MOLDENHAUER, G. and MOMBURG, F., Defective expression of MHC class I antigens is frequent in B-cell lymphomas of high-grade malignancy. Int. J. Cancer, 40, 32-39 (1987).
19. MURRAY, R.J., KURILLA, M.G., BROOKS, J.M., THOMAS, W.A., ROWE, M., KIEFF, E. and RICKINSON, A.B., Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. J. exp. Med., 176, 157-168 (1992).
20. MURRAY, R.J., WANG, D., YOUNG, L.S., WANG, F., ROWE, M., KIEFF, E. and RICKINSON, A.B., Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP. J. Virol., 62, 3747-3755 (1988).
21. OHSAWA, M., TOMITA, Y., KANNO, H., IUCHI, K., KAWABATA, Y., NAKAJIMA, Y., KOMATSU, H., MUKAI, K., SHIMOYAMA, M. and AOZASA, K., Role of Epstein-Barr virus in pleural lymphomagenesis. Mod. Pathol., 8, 848-853 (1995).
22. PARHAM, P., BARNSTABLE, C.J. and BOOMER, W.F., Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C antigens. J. Immunol., 123, 342-349 (1979).
23. RICKINSON, A.B., MURRAY, R.J., BROOKS, J., GRIFFIN, H., Moss, D.J. and MASUCCI, M.G., T cell recognition of Epstein-Barr virus associated lymphomas. Cancer Surv., 13, 53-80 (1992).
24. ROWE, M., YOUNG, L.S., CROCKER, J., STOKES, H., HENDERSON, S. and RICKINSON, A.B., Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man. J. exp. Med., 173, 147-158 (1991).
25. SHIBATA, D., WEISS, L.M., HERNANDEZ, A.M., NATHWANI, B.N., BERNSTEIN, L. and LEVINE, A.M., Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients infected with the human immunodeficiency virus. Blood, 81, 2102-2109 (1993).
26. THOMAS, J.A., HOTCHIN, N.A., ALLDAY, M.J., AMLOT, P., ROSE, M., YACOUB, M. and CRAWFORD, D.H., Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals. Transplantation, 49, 944-953 (1990).
27. TOMITA, Y., OHSAWA, M., KANNO, H., HASHIMOTO, M., OHNISHI, A., NAKANISHI, H. and AOZASA, K., Epstein-Barr virus in Hodgkin's disease patients in Japan. Cancer, 77, 186-192 (1996).